s6y

MetaVia Inc.

Ticker
MTVA
CIK
1638287
Industry
Pharmaceutical Preparations
Formerly
NeuroBo Pharmaceuticals, Inc., Gemphire Therapeutics Inc.

Financials 46

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K Annual Report for period ending Dec 31, 2025
  5. 10-Q Quarterly Report for period ending Sep 30, 2025
  6. 10-Q Quarterly Report for period ending Jun 30, 2025
  7. 10-Q Quarterly Report for period ending Mar 31, 2025
  8. 10-K Annual Report for period ending Dec 31, 2024
  9. 10-Q Quarterly Report for period ending Sep 30, 2024
  10. 10-Q Quarterly Report for period ending Jun 30, 2024

All 46 financials filings

News 195

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 195 news filings

Ownership 198

  1. 4 Statement of changes in beneficial ownership of securities
  2. 3 Initial statement of beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 198 ownership filings

Prospectus 78

  1. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  2. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  3. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  4. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  5. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  6. S-1MEF A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1
  7. S-1/A General form of registration statement for all companies including face-amount certificate companies
  8. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  9. S-1 General form of registration statement for all companies including face-amount certificate companies
  10. 424B5 Prospectus filed pursuant to Rule 424(b)(5)

All 78 prospectus filings

Proxies 22

  1. DEF 14A Definitive proxy statements
  2. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  3. DEF 14A Definitive proxy statements
  4. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  5. DEF 14A Definitive proxy statements
  6. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  7. DEF 14A Definitive proxy statements
  8. DEF 14A Definitive proxy statements
  9. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  10. DEF 14A Definitive proxy statements

All 22 proxies filings

Other 100

  1. SCHEDULE 13G
  2. ARS Annual report to security holders
  3. EFFECT Notice of Effectiveness
  4. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  5. EFFECT Notice of Effectiveness
  6. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  7. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  8. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  9. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  10. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

All 100 other filings